Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
American WellAMWL +0.17%50 PS Ratio is 0.90 as of Aug. 25, 2026, which is 40% below its 10-year median of 1.51. GuruFocus rates AMWL with a GF Score™ of 50/100 and a GF Value™ of $6.42 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 659 Healthcare Providers & Services companies, American Well ranks better than 66.46% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, American Well's share price is $11.92.
American Well's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $13.26. Hence, American Well's PS Ratio for today is 0.90.
The historical rank and industry rank for American Well's PS Ratio or its related term are showing as below:
AMWL'
s PS Ratio Range Over the Past 10 Years
Min: 0.23 Med: 1.51 Max: 25.53
Current: 0.88
During the past 8 years, American Well's highest PS Ratio was 25.53. The lowest was 0.23. And the median was 1.51.
AMWL's PS Ratio is ranked better than 66.46% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs AMWL: 0.88
American Well Corp revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of American Well was -23.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -8.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -16.70% per year.
During the past 8 years, American Well's highest 3-Year average Revenue per Share Growth Rate was 14.10% per year. The lowest was -28.30% per year. And the median was -5.20% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
American Well PS Ratio Related Terms
American Well PS Ratio Historical Data
* Premium members only.
The historical data trend for American Well's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, American Well's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Well PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, American Well's PS Ratio distribution charts can be found below:
* The bar in red indicates where American Well's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
American Well's Share Price of today is $11.92. American Well's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
American Well (AMWL) has a PS Ratio of 0.90 as of Aug. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on American Well and its competitors. This is 40% below median its historical median of 1.51. Over the past decade, American Well's PS Ratio has ranged from 0.23 to 25.53. According to the industry distribution chart, American Well ranks #221 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 33.5%.
Is American Well's PS Ratio too high?
American Well's current PS Ratio of 0.90 is 40% below median its 10-year median of 1.51. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 25.53. The Healthcare Providers & Services industry median PS Ratio is 1.52. American Well's value of 0.90 is 40.8% below this industry median. Based on the distribution chart, American Well ranks #221 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, American Well has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does American Well's PS Ratio compare to LFMD and SY?
According to the Healthcare Providers & Services industry distribution chart, American Well ranks #221 out of 659 companies for PS Ratio. This puts American Well in the upper half of its industry. The industry median PS Ratio is 1.52. American Well's value of 0.90 is 40.8% below this benchmark. Historically, American Well's own PS Ratio has ranged from 0.23 to 25.53 over the past decade. While the company's 10-year median is 1.51 vs. the industry median of 1.52, American Well has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. American Well's current PS Ratio of 0.90 is 40.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on American Well and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. American Well's current PS Ratio is 0.90, which is 40% below median its own 10-year median of 1.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Well stock overvalued right now?
Based on GuruFocus' analysis, American Well (AMWL) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.42, compared to a current price of $11.92 — trading 85.7% above its estimated fair value. The current PS Ratio is 0.90, which is 40% below median its 10-year median of 1.51 and 40.8% below the Healthcare Providers & Services industry median of 1.52. American Well's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For American Well (AMWL), the current PS Ratio is 0.90 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is American Well (AMWL) Overvalued in 2026?
Based on GuruFocus' analysis, American Well stock appears to be overvalued.
The current stock price of $11.92 is trading 85.7% above its estimated GF Value™ of $6.42.
GuruFocus considers American Well to be Significantly Overvalued.
Key valuation signals for AMWL:
PS Ratio: 0.90 (40% below median its 10-year median of 1.51)
GF Value™: $6.42 vs. price of $11.92 (85.7% above fair value)
Industry Position: 40.8% below the Healthcare Providers & Services median (#221 of 659)
No single metric tells the full story. See the AMWL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
50GF Score
Get the complete analysis for AMWL
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMWL has been successfully added to your 
